Ulf Bergman

Ulf Bergman

Affiliated to Research
Visiting address: Avd.För klinisk Farmakologi C1:68, Karolinska Universitetssjukhuset, 14186 Stockholm
Postal address: H5 Laboratoriemedicin, H5 Klin Farmakologi, 141 52 Huddinge
Part of:

About me

  • Ulf Bergman MD, Ph.D., Professor (guest) at the Centre for
    Pharmacoepidemiology, Karolinska Institutet, and Senior Medical Officer,
    Division of Clinical Pharmacology, Karolinska University Hospital, Stockholm,
    Sweden

Research

  • In the areas of drug utilisation research/pharmacoepidemiology, TDM, quality
    indicators, adverse drug reaction evaluations and drug abuse he is providing
    clinical pharmacological service, teaching (tutor for twelve graduate
    students) and research (more than 200 scientific publications, numerous
    reviews, book chapters etc). He is a temporary advisor to the WHO: Copenhagen
    since1976 and Geneva since 2000. He was the deputy Director of the WHO
    Collaborating Center for Drug Utilization Research and Clinical
    Pharmacological Services at the Division of Clinical Pharmacology for many
    years.
    He is currently observer at the WHO International Working Group for Drug
    Statistics Methodology for the WHO Collaborating Center for Drug Statistics
    Methodology, Oslo, Norway (ATC/DDD). He was a deputy Member of the Board of
    the Uppsala Monitoring Center, WHO Collaborating Center for International
    Drug Monitoring (adverse drug reactions) for ten years.
    He is also a founding member of the European Drug Utilization Research Group
    (EuroDURG) and the International Society for Pharmacoepidemiology ISPE.
    *Publications*
    [pubmed:21071484]
    [pubmed:21414143]
    [pubmed:21994316]
    *Lee D, Bergman U.*
    Studies of Drug Utilization.
    /Pharmacoepidemiology. Editors: B Strom, S Kimmel &
  • S Hennessy. 5th Edition.
    Wiley-Blackwell, pp 379-401, 2012/

Articles

All other publications

News from KI

Events from KI